Jim Cramer on Cardinal Health: “It’s Been a Real Stalwart, and I Don’t Think It’s Done”

Cardinal Health, Inc. (NYSE:CAH) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday’s market rotation. Cramer said that the stock deserves to “trade higher,” as he commented:

Can I call your attention to what may be the best one in this group? I’m talking about Cardinal Health, which, along with McKesson and Cencora, deserves to trade higher. Great quarter at Cardinal Health. It was obscured by a rotation out of healthcare. Oh, we own this one for the Trust. It’s been a real stalwart, and I don’t think it’s done.

Cardinal Health, Inc. (NYSE:CAH) supplies branded, generic, and specialty medicines and provides pharmacy and specialty drug services. The company also makes and distributes medical and surgical products and procedure kits. Cramer mentioned the stock during the April 30 episode and remarked:

Cardinal Health, a company that had repeatedly come on Mad Money telling a terrific story, just imploded. Did I tell people to buy it? Well, it’s in my Trust. Ouch. Gotta put that one behind, but only after further investigation.

While we acknowledge the risk and potential of CAH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CAH and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1